In Vitro Study of Methanolic Extract of Eclipta Alba Hassk. for HepG2 Cell Line
January 2020
in “
Ayurline: IJ-RIM
”
New to Eclipta Alba? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that Eclipta alba Hassk. (Bhrungraj) significantly inhibited the growth of human liver cancer cells, suggesting its potential as an anticancer agent.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the anticancer properties of the methanolic extract of Eclipta alba Hassk., commonly known as Bhrungraj, on the HepG2 human liver cancer cell line. Traditionally used in Ayurveda for hair growth and as a hepatoprotective agent, Bhrungraj demonstrated significant anticancer activity in this in vitro study. The sulforhodamine B (SRB) assay results showed an average growth inhibition of 77.36% in the HepG2 cells, indicating its potential as an effective anticancer agent. The findings supported further exploration of Bhrungraj extracts for anticancer applications.
